Cargando…

Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

Detalles Bibliográficos
Autores principales:	Chui, M. Herman, Kjaer, Susanne K., Frederiksen, Kirsten, Hannibal, Charlotte G., Wang, Tian-Li, Vang, Russell, Shih, Ie-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238241/ https://www.ncbi.nlm.nih.gov/pubmed/34194631 http://dx.doi.org/10.18632/oncotarget.28001

Ejemplares similares

BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
por: Chui, M. Herman, et al.
Publicado: (2019)

Risk of nonovarian cancer in a nationwide‐based study of nearly 5000 women with borderline ovarian tumors in Denmark
por: Hannibal, Charlotte G., et al.
Publicado: (2022)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
por: Gross, Amy L., et al.
Publicado: (2010)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation
por: Nakai, Go, et al.
Publicado: (2018)

Histopathological Patterns of Microinvasion in Ovarian Serous Borderline Tumors
por: CÎRSTEA, A.E., et al.
Publicado: (2018)

Paratubal serous borderline tumor
por: Shin, You-Jung, et al.
Publicado: (2011)

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma
por: Tholander, Bengt, et al.
Publicado: (2020)

Impressive and durable clinical responses obtained with dabrafenib and trametinib in low-grade serous ovarian cancer harbouring a BRAF V600E mutation
por: Lima, Bárbara, et al.
Publicado: (2022)

Serous borderline tumor of the fallopian tube
por: Choi, So Mi, et al.
Publicado: (2014)

A Rare Case of Ovarian Serous Borderline Tumor with Brain Metastasis
por: Veran-Taguibao, Sonia, et al.
Publicado: (2019)

Identification of clinical and molecular features of recurrent serous borderline ovarian tumour
por: Lu, Ziyang, et al.
Publicado: (2022)

A serous borderline ovarian tumour in a transgender male adolescent
por: Millington, Kate, et al.
Publicado: (2020)

The Multimodal Ultrasound Features of Ovarian Serous Surface Papillary Borderline Tumor
por: Xie, Lijun, et al.
Publicado: (2022)

Bilateral Ovarian Serous Borderline Tumor with Non-Invasive Endometrial Implants
por: Malham, Melissa Bou, et al.
Publicado: (2023)

A rare mixed ovarian tumor associating borderline endometrioid component and borderline serous component
por: Hammouda, Seifeddine Ben, et al.
Publicado: (2022)

Mutational Analysis of KRAS, BRAF, and TP53 Genes of Ovarian Serous Carcinomas in Korean Women
por: Cho, Yun-Hyun, et al.
Publicado: (2009)

Digital Pathology-based Study of Cell- and Tissue-level Morphologic Features in Serous Borderline Ovarian Tumor and High-grade Serous Ovarian Cancer
por: Jiang, Jun, et al.
Publicado: (2021)

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
por: Ducie, Jennifer, et al.
Publicado: (2017)

An uncommon paratubal cyst: Serous borderline tumor
por: Limaiem, Faten, et al.
Publicado: (2023)

Serous Borderline Ovarian Tumor Diagnosis, Management and Fertility Preservation in Young Women
por: Carbonnel, Marie, et al.
Publicado: (2021)

Fertility-Preserving Surgery of Borderline Serous Ovarian Tumors: A Case Report
por: Mohapatra, Ipsita, et al.
Publicado: (2022)

TGF-Beta Induces Serous Borderline Ovarian Tumor Cell Invasion by Activating EMT but Triggers Apoptosis in Low-Grade Serous Ovarian Carcinoma Cells
por: Cheng, Jung-Chien, et al.
Publicado: (2012)

Osseous Metaplasia in Low-grade Ovarian Serous Carcinoma With a BRAF Mutation: A Case Report
por: Catteau, Xavier, et al.
Publicado: (2021)

Dramatic clinical response following dabrafenib and trametinib therapy in a heavily pretreated low grade serous ovarian carcinoma patient with a BRAF V600E mutation
por: Mendivil, Alberto A., et al.
Publicado: (2018)

Mutational heterogeneity in non-serous ovarian cancers
por: Teer, Jamie K., et al.
Publicado: (2017)

Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors
por: Lu, Ziyang, et al.
Publicado: (2019)

EGF-Induced EMT and Invasiveness in Serous Borderline Ovarian Tumor Cells: A Possible Step in the Transition to Low-Grade Serous Carcinoma Cells?
por: Cheng, Jung-Chien, et al.
Publicado: (2012)

Low-grade serous ovarian cancer: expert consensus report on the state of the science
por: Grisham, Rachel N, et al.
Publicado: (2023)

Paratesticular Serous Borderline Tumor in a Pediatric Patient
por: Meza, Itzel Araceli Ortiz, et al.
Publicado: (2020)

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
por: Smith, Philip, et al.
Publicado: (2023)

Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging
por: Kurata, Yasuhisa, et al.
Publicado: (2017)

Mucinous borderline ovarian tumors with BRAF(V600E) mutation may have low risk for progression to invasive carcinomas
por: Ohnishi, Kaori, et al.
Publicado: (2020)

CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells
por: Qiu, X, et al.
Publicado: (2015)

KRAS Mutation in Serous Borderline Tumor of the Testis: Report of a Case and Review of the Literature
por: Bouri, Sarah, et al.
Publicado: (2020)

Fine needle aspiration cytology of cervical lymph node involvement by ovarian serous borderline tumor
por: Chen, Longwen, et al.
Publicado: (2016)

Borderline serous ovarian neoplasm: case report of a diagnostic challenge in intraoperative frozen sections
por: Rana, Farah, et al.
Publicado: (2020)

Investigating a clinically actionable BRAF mutation for monitoring low-grade serous ovarian cancer: A case report
por: Silva, R., et al.
Publicado: (2022)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_100gf1v27gg1o6qdnn5pmbcj5u